Clinical Trial Update: Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody Injection [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of a recombinant human anti-tetanus toxin monoclonal antibody inj…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tetanus

Drugs mentioned

• Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody Injection (anti-tetanus toxin monoclonal antibody)

Snippet

Sponsor: Lanzhou Institute of Biological Products Co., Ltd | Conditions: Tetanus | Phase 1 | Status: ENROLLING_BY_INVITATION